List of Tables
    Table 1. Global Antidepressant Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Antidepressant Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Antidepressant Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Antidepressant Drugs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Antidepressant Drugs Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Antidepressant Drugs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Antidepressant Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Antidepressant Drugs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Antidepressant Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Antidepressant Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers Antidepressant Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Antidepressant Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidepressant Drugs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Antidepressant Drugs Sales by Region (2017-2022) & (K Units)
    Table 16. Global Antidepressant Drugs Sales Market Share by Region (2017-2022)
    Table 17. Global Antidepressant Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Antidepressant Drugs Revenue Market Share by Region (2017-2022)
    Table 19. North America Antidepressant Drugs Sales by Country (2017-2022) & (K Units)
    Table 20. North America Antidepressant Drugs Sales Market Share by Country (2017-2022)
    Table 21. North America Antidepressant Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Antidepressant Drugs Revenue Market Share by Country (2017-2022)
    Table 23. Europe Antidepressant Drugs Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Antidepressant Drugs Sales Market Share by Country (2017-2022)
    Table 25. Europe Antidepressant Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Antidepressant Drugs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Antidepressant Drugs Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Antidepressant Drugs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Antidepressant Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Antidepressant Drugs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Antidepressant Drugs Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Antidepressant Drugs Sales Market Share by Country (2017-2022)
    Table 33. Latin America Antidepressant Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Antidepressant Drugs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Antidepressant Drugs Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Antidepressant Drugs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Antidepressant Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Antidepressant Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Global Antidepressant Drugs Sales by Type (2017-2022) & (K Units)
    Table 40. Global Antidepressant Drugs Sales Market Share by Type (2017-2022)
    Table 41. Global Antidepressant Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Antidepressant Drugs Revenue Share by Type (2017-2022)
    Table 43. Global Antidepressant Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Antidepressant Drugs Sales (K Units) by Application (2017-2022)
    Table 45. Global Antidepressant Drugs Sales Market Share by Application (2017-2022)
    Table 46. Global Antidepressant Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Antidepressant Drugs Revenue Share by Application (2017-2022)
    Table 48. Global Antidepressant Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 49. Pfizer Corporation Information
    Table 50. Pfizer Description and Business Overview
    Table 51. Pfizer Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Pfizer Antidepressant Drugs Product
    Table 53. Pfizer Recent Developments/Updates
    Table 54. Mylan Corporation Information
    Table 55. Mylan Description and Business Overview
    Table 56. Mylan Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Mylan Antidepressant Drugs Product
    Table 58. Mylan Recent Developments/Updates
    Table 59. Bayer Corporation Information
    Table 60. Bayer Description and Business Overview
    Table 61. Bayer Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Bayer Antidepressant Drugs Product
    Table 63. Bayer Recent Developments/Updates
    Table 64. Eli Lilly Corporation Information
    Table 65. Eli Lilly Description and Business Overview
    Table 66. Eli Lilly Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Eli Lilly Antidepressant Drugs Product
    Table 68. Eli Lilly Recent Developments/Updates
    Table 69. Claire Ellen Corporation Information
    Table 70. Claire Ellen Description and Business Overview
    Table 71. Claire Ellen Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Claire Ellen Antidepressant Drugs Product
    Table 73. Claire Ellen Recent Developments/Updates
    Table 74. Sanofi S.A Corporation Information
    Table 75. Sanofi S.A Description and Business Overview
    Table 76. Sanofi S.A Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. Sanofi S.A Antidepressant Drugs Product
    Table 78. Sanofi S.A Recent Developments/Updates
    Table 79. Meda AB Corporation Information
    Table 80. Meda AB Description and Business Overview
    Table 81. Meda AB Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. Meda AB Antidepressant Drugs Product
    Table 83. Meda AB Recent Developments/Updates
    Table 84. Boehringer Ingelheim Corporation Information
    Table 85. Boehringer Ingelheim Description and Business Overview
    Table 86. Boehringer Ingelheim Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. Boehringer Ingelheim Antidepressant Drugs Product
    Table 88. Boehringer Ingelheim Recent Developments/Updates
    Table 89. Pierre Fabre Corporation Information
    Table 90. Pierre Fabre Description and Business Overview
    Table 91. Pierre Fabre Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 92. Pierre Fabre Antidepressant Drugs Product
    Table 93. Pierre Fabre Recent Developments/Updates
    Table 94. Cipla Corporation Information
    Table 95. Cipla Description and Business Overview
    Table 96. Cipla Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 97. Cipla Antidepressant Drugs Product
    Table 98. Cipla Recent Developments/Updates
    Table 99. APOTEX Corporation Information
    Table 100. APOTEX Description and Business Overview
    Table 101. APOTEX Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 102. APOTEX Antidepressant Drugs Product
    Table 103. APOTEX Recent Developments/Updates
    Table 104. PRINSTON INC Corporation Information
    Table 105. PRINSTON INC Description and Business Overview
    Table 106. PRINSTON INC Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 107. PRINSTON INC Antidepressant Drugs Product
    Table 108. PRINSTON INC Recent Developments/Updates
    Table 109. TEVA Corporation Information
    Table 110. TEVA Description and Business Overview
    Table 111. TEVA Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. TEVA Antidepressant Drugs Product
    Table 113. TEVA Recent Developments/Updates
    Table 114. ROXANE Corporation Information
    Table 115. ROXANE Description and Business Overview
    Table 116. ROXANE Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. ROXANE Antidepressant Drugs Product
    Table 118. ROXANE Recent Developments/Updates
    Table 119. ZYDUS PHARMS Corporation Information
    Table 120. ZYDUS PHARMS Description and Business Overview
    Table 121. ZYDUS PHARMS Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. ZYDUS PHARMS Antidepressant Drugs Product
    Table 123. ZYDUS PHARMS Recent Developments/Updates
    Table 124. SUN PHARM Corporation Information
    Table 125. SUN PHARM Description and Business Overview
    Table 126. SUN PHARM Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. SUN PHARM Antidepressant Drugs Product
    Table 128. SUN PHARM Recent Developments/Updates
    Table 129. JUBILANT GENERICS Corporation Information
    Table 130. JUBILANT GENERICS Description and Business Overview
    Table 131. JUBILANT GENERICS Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 132. JUBILANT GENERICS Antidepressant Drugs Product
    Table 133. JUBILANT GENERICS Recent Developments/Updates
    Table 134. GlaxoSmithKline Corporation Information
    Table 135. GlaxoSmithKline Description and Business Overview
    Table 136. GlaxoSmithKline Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 137. GlaxoSmithKline Antidepressant Drugs Product
    Table 138. GlaxoSmithKline Recent Developments/Updates
    Table 139. Beijing Wansheng Corporation Information
    Table 140. Beijing Wansheng Description and Business Overview
    Table 141. Beijing Wansheng Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 142. Beijing Wansheng Antidepressant Drugs Product
    Table 143. Beijing Wansheng Recent Developments/Updates
    Table 144. Huahai Corporation Information
    Table 145. Huahai Description and Business Overview
    Table 146. Huahai Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 147. Huahai Antidepressant Drugs Product
    Table 148. Huahai Recent Developments/Updates
    Table 149. Jianfeng Corporation Information
    Table 150. Jianfeng Description and Business Overview
    Table 151. Jianfeng Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 152. Jianfeng Antidepressant Drugs Product
    Table 153. Jianfeng Recent Developments/Updates
    Table 154. Cadista Corporation Information
    Table 155. Cadista Description and Business Overview
    Table 156. Cadista Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 157. Cadista Antidepressant Drugs Product
    Table 158. Cadista Recent Developments/Updates
    Table 159. Carbosynth Limited Corporation Information
    Table 160. Carbosynth Limited Description and Business Overview
    Table 161. Carbosynth Limited Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 162. Carbosynth Limited Antidepressant Drugs Product
    Table 163. Carbosynth Limited Recent Developments/Updates
    Table 164. LGM Pharma Corporation Information
    Table 165. LGM Pharma Description and Business Overview
    Table 166. LGM Pharma Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 167. LGM Pharma Antidepressant Drugs Product
    Table 168. LGM Pharma Recent Developments/Updates
    Table 169. Intellipharmaceutics Corporation Information
    Table 170. Intellipharmaceutics Description and Business Overview
    Table 171. Intellipharmaceutics Antidepressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 172. Intellipharmaceutics Antidepressant Drugs Product
    Table 173. Intellipharmaceutics Recent Developments/Updates
    Table 174. Production Base and Market Concentration Rate of Raw Material
    Table 175. Key Suppliers of Raw Materials
    Table 176. Antidepressant Drugs Distributors List
    Table 177. Antidepressant Drugs Customers List
    Table 178. Antidepressant Drugs Market Trends
    Table 179. Antidepressant Drugs Market Drivers
    Table 180. Antidepressant Drugs Market Challenges
    Table 181. Antidepressant Drugs Market Restraints
    Table 182. Global Antidepressant Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 183. Global Antidepressant Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 184. Global Antidepressant Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 185. Global Antidepressant Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 186. Global Antidepressant Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 187. Global Antidepressant Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 188. Global Antidepressant Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 189. Global Antidepressant Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 190. Global Antidepressant Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 191. Global Antidepressant Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 192. Global Antidepressant Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 193. Global Antidepressant Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 194. Research Programs/Design for This Report
    Table 195. Key Data Information from Secondary Sources
    Table 196. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Antidepressant Drugs
    Figure 2. Global Antidepressant Drugs Market Share by Type in 2021 & 2028
    Figure 3. SSRIs Product Picture
    Figure 4. SNRIs Product Picture
    Figure 5. TCAs Product Picture
    Figure 6. MAOIs Product Picture
    Figure 7. TeCAs Product Picture
    Figure 8. NaSSAs Product Picture
    Figure 9. RMAO-A Inhibitors Product Picture
    Figure 10. Global Antidepressant Drugs Market Share by Application in 2021 & 2028
    Figure 11. Anxiety Disorders
    Figure 12. Eating Disorders\
    Figure 13. Pain
    Figure 14. Others
    Figure 15. Global Antidepressant Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Antidepressant Drugs Market Size (2017-2028) & (US$ Million)
    Figure 17. Global Antidepressant Drugs Sales (2017-2028) & (K Units)
    Figure 18. Antidepressant Drugs Sales Share by Manufacturers in 2021
    Figure 19. Global Antidepressant Drugs Revenue Share by Manufacturers in 2021
    Figure 20. The Global 5 and 10 Largest Antidepressant Drugs Players: Market Share by Revenue in 2021
    Figure 21. Antidepressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 22. Global Antidepressant Drugs Sales Market Share by Region (2017-2022)
    Figure 23. Global Antidepressant Drugs Sales Market Share by Region in 2021
    Figure 24. Global Antidepressant Drugs Revenue Market Share by Region (2017-2022)
    Figure 25. Global Antidepressant Drugs Revenue Market Share by Region in 2021
    Figure 26. U.S. Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Canada Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Germany Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. France Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. U.K. Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Italy Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Russia Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. China Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Japan Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. South Korea Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. India Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Australia Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Taiwan Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Indonesia Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Thailand Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Malaysia Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Philippines Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Vietnam Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Mexico Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Brazil Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Argentina Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Turkey Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Saudi Arabia Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 49. U.A.E Antidepressant Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 50. Sales Market Share of Antidepressant Drugs by Type (2017-2022)
    Figure 51. Manufacturing Cost Structure of Antidepressant Drugs
    Figure 52. Manufacturing Process Analysis of Antidepressant Drugs
    Figure 53. Antidepressant Drugs Industrial Chain Analysis
    Figure 54. Channels of Distribution
    Figure 55. Distributors Profiles
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed